Raffles Medical Group Future Growth
Future criteria checks 3/6
Raffles Medical Group is forecast to grow earnings and revenue by 12.6% and 4% per annum respectively. EPS is expected to grow by 10.9% per annum. Return on equity is forecast to be 7.3% in 3 years.
Key information
12.6%
Earnings growth rate
10.9%
EPS growth rate
| Healthcare earnings growth | 18.4% |
| Revenue growth rate | 4.0% |
| Future return on equity | 7.3% |
| Analyst coverage | Good |
| Last updated | 01 Aug 2024 |
Recent future growth updates
Recent updates
Raffles Medical Group (SGX:BSL) Is Reducing Its Dividend To SGD0.024
May 09
Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024
Apr 25Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 10Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)
Nov 16Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price
Nov 03Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors
Aug 23The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising
Jul 24Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt
Jun 13A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)
May 30Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?
May 12Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038
May 01Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger
Mar 13Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)
Feb 14Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up
Dec 04Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?
Nov 21Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?
Oct 09Is Raffles Medical Group (SGX:BSL) A Risky Investment?
Sep 26The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising
Sep 01With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case
Aug 20Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger
Jun 01Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028
May 02We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease
Apr 18Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement
Feb 21Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly
Oct 14Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger
Oct 02At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?
Sep 21Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock
Aug 12Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital
Jul 01At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?
May 25Does This Valuation Of Raffles Medical Group Ltd (SGX:BSL) Imply Investors Are Overpaying?
Apr 05Returns On Capital At Raffles Medical Group (SGX:BSL) Paint A Concerning Picture
Mar 24Is Raffles Medical Group (SGX:BSL) Using Too Much Debt?
Mar 12Robust Earnings May Not Tell The Whole Story For Raffles Medical Group (SGX:BSL)
Feb 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 821 | 83 | 106 | 125 | 5 |
| 12/31/2025 | 785 | 78 | 100 | 122 | 8 |
| 12/31/2024 | 741 | 69 | -74 | 98 | 8 |
| 6/30/2024 | 703 | 61 | 72 | 97 | N/A |
| 3/31/2024 | 706 | 76 | 120 | 143 | N/A |
| 12/31/2023 | 708 | 90 | 167 | 189 | N/A |
| 9/30/2023 | 747 | 117 | 166 | 189 | N/A |
| 6/30/2023 | 786 | 144 | 165 | 188 | N/A |
| 3/31/2023 | 805 | 143 | 168 | 192 | N/A |
| 12/31/2022 | 825 | 143 | 171 | 196 | N/A |
| 9/30/2022 | 808 | 124 | 179 | 204 | N/A |
| 6/30/2022 | 791 | 104 | 188 | 212 | N/A |
| 3/31/2022 | 758 | 94 | 148 | 186 | N/A |
| 12/31/2021 | 725 | 84 | 107 | 160 | N/A |
| 9/30/2021 | 698 | 86 | 108 | 171 | N/A |
| 6/30/2021 | 671 | 88 | 109 | 181 | N/A |
| 3/31/2021 | 619 | 77 | 91 | 157 | N/A |
| 12/31/2020 | 568 | 66 | 73 | 133 | N/A |
| 9/30/2020 | 541 | 60 | 42 | 121 | N/A |
| 6/30/2020 | 508 | 50 | 23 | 105 | N/A |
| 3/31/2020 | 514 | 55 | 21 | 107 | N/A |
| 12/31/2019 | 522 | 60 | 13 | 111 | N/A |
| 9/30/2019 | 514 | 63 | 16 | 93 | N/A |
| 6/30/2019 | 504 | 66 | 28 | 92 | N/A |
| 3/31/2019 | 497 | 69 | 35 | 89 | N/A |
| 12/31/2018 | 489 | 71 | 62 | 94 | N/A |
| 9/30/2018 | 484 | 71 | 63 | 88 | N/A |
| 6/30/2018 | 483 | 71 | 57 | 81 | N/A |
| 3/31/2018 | 483 | 71 | N/A | 88 | N/A |
| 12/31/2017 | 478 | 71 | N/A | 83 | N/A |
| 9/30/2017 | 473 | 70 | N/A | 81 | N/A |
| 6/30/2017 | 473 | 70 | N/A | 65 | N/A |
| 3/31/2017 | 472 | 70 | N/A | 63 | N/A |
| 12/31/2016 | 474 | 70 | N/A | 79 | N/A |
| 9/30/2016 | 470 | 71 | N/A | 83 | N/A |
| 6/30/2016 | 452 | 71 | N/A | 92 | N/A |
| 3/31/2016 | 432 | 70 | N/A | 91 | N/A |
| 12/31/2015 | 411 | 69 | N/A | 73 | N/A |
| 9/30/2015 | 396 | 69 | N/A | 86 | N/A |
| 6/30/2015 | 389 | 68 | N/A | 79 | N/A |
| 3/31/2015 | 382 | 68 | N/A | 94 | N/A |
| 12/31/2014 | 375 | 68 | N/A | 93 | N/A |
| 9/30/2014 | 363 | 89 | N/A | 66 | N/A |
| 6/30/2014 | 353 | 87 | N/A | 83 | N/A |
| 3/31/2014 | 347 | 86 | N/A | 71 | N/A |
| 12/31/2013 | 341 | 85 | N/A | 71 | N/A |
| 9/30/2013 | 336 | 62 | N/A | 87 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BSL's forecast earnings growth (12.6% per year) is above the savings rate (2.2%).
Earnings vs Market: BSL's earnings (12.6% per year) are forecast to grow faster than the SG market (10% per year).
High Growth Earnings: BSL's earnings are forecast to grow, but not significantly.
Revenue vs Market: BSL's revenue (4% per year) is forecast to grow faster than the SG market (3.7% per year).
High Growth Revenue: BSL's revenue (4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BSL's Return on Equity is forecast to be low in 3 years time (7.3%).